Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has been updated to reflect that some services are experiencing heavy traffic, and the status has changed to 'Active, not recruiting'. Additionally, several dates have been updated to 2025, indicating a shift in timelines.SummaryDifference2%
- Check39 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.SummaryDifference0.2%
- Check89 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.